Autonomix Medical, Inc. (NASDAQ:AMIX) Sees Large Decline in Short Interest

Autonomix Medical, Inc. (NASDAQ:AMIX) was the target of a significant drop in short interest during the month of June. As of June 15th, there was short interest totaling 344,031 shares, a drop of 46.8% from the May 31st total of 646,074 shares. Approximately 5.3% of the shares of the stock are sold short. Based on an average trading volume of 146,755 shares, the days-to-cover ratio is presently 2.3 days.

Analysts Set New Price Targets

A number of equities research analysts have weighed in on the company. Zacks Research raised Autonomix Medical to a “hold” rating in a report on Tuesday, June 2nd. Weiss Ratings raised Autonomix Medical from a “sell (e)” rating to a “sell (e+)” rating in a report on Tuesday, June 23rd. One equities research analyst has rated the stock with a Buy rating, one has assigned a Hold rating and one has assigned a Sell rating to the stock. According to data from MarketBeat, Autonomix Medical currently has a consensus rating of “Hold” and a consensus target price of $42.00.

Autonomix Medical Price Performance

AMIX stock opened at $5.84 on Tuesday. The company has a 50 day simple moving average of $7.76 and a 200 day simple moving average of $9.01. The stock has a market cap of $3.15 million, a price-to-earnings ratio of -0.08 and a beta of -1.44. Autonomix Medical has a 1 year low of $4.20 and a 1 year high of $55.44.

About Autonomix Medical

Autonomix Medical, Inc, a development stage medical device development company, focuses on advancing technologies for sensing and treating disorders relating to the peripheral nervous system. Its technology platform includes a catheter-based microchip-enabled sensing array to detect and differentiate peripheral neural signals. The company was incorporated in 2014 and is based in The Woodlands, Texas.